Rheumatology

Real-world study results suggest that less than a third of patients with giant cell arteritis and/or polymyalgia rheumatica are able to discontinue glucocorticoid treatment for at least 6 months, and a substantial proportion remain on prednisone for at least 2 years.

Cognitive behavioral therapy for insomnia could be delivered via the telephone to patients with osteoarthritis, proving useful for those unable to access in-person options, OATS trial findings suggest.

Following myocardial infarction, people with rheumatoid arthritis have an elevated long-term risk for mortality and further cardiovascular disease events, researchers report.

Twelve weeks of high-dose vitamin D supplementation does not improve pain levels for women with fibromyalgia, research suggests.

Researchers have found that adolescents with chronic musculoskeletal pain, particularly those with gastrointestinal problems, may be at risk for disordered eating.

People with psoriatic arthritis may have an elevated risk for type 2 diabetes that is mediated in part by BMI, researchers report.

Two studies have evaluated the perspectives of people with rheumatic and musculoskeletal diseases on COVID-19 vaccination, with both finding that a physician’s recommendation would improve patients’ willingness to be vaccinated.

Real-world data confirm the effectiveness of tocilizumab for decreasing relapse risk and allowing corticosteroid reduction in heavily treated patients with giant cell arteritis.

The phase 3 POSTURE trial has demonstrated no clinical benefit of apremilast for patients with active ankylosing spondylitis and no prior exposure to biologic agents.

Older people with late-onset rheumatoid arthritis show a similar response to biologic or targeted synthetic DMARDs to their peers whose disease onset was earlier in life, Japanese study findings indicate.

High-intensity strength training does not significantly reduce pain or knee joint compressive forces among people with knee osteoarthritis, suggest findings from the START trial.

Using musculoskeletal ultrasound alongside other triage modalities may improve the detection of psoriatic arthritis among patients with psoriasis and musculoskeletal symptoms, researchers report.

Interstitial lung disease is present in nearly 5% of patients with rheumatoid arthritis and can increase the risk for death, report researchers.

IL-1 inhibition is associated with a significant reduction in overall mortality risk among hospitalized patients with COVID-19 and hyperinflammation, while patients with markedly elevated C-reactive protein or low lactate dehydrogenase may benefit from IL-6 inhibition, researchers report.

The American College of Rheumatology has issued clinical guidance recommending COVID-19 vaccination for people with rheumatic and musculoskeletal diseases.

medwireNews: Long-term treatment with tanezumab is associated with an increased risk for joint-related adverse events in patients with hip or knee osteoarthritis and moderate-to-severe pain despite prior stable use of NSAIDs, phase 3 study data show.

EULAR has issued guidance on the pathophysiology of COVID-19 and the potential use of immunomodulatory therapies for its treatment.

The majority of patients with rheumatoid arthritis do not receive appropriate foot care, UK research suggests.

Individuals with a wide range of anti-modified protein antibodies experience higher rates of early radiographic progression than those with just a single antibody type, show data from the Scottish Early Rheumatoid Arthritis inception cohort.

Click through for more information on this Drug Safety Communication